XML 146 R26.htm IDEA: XBRL DOCUMENT v3.25.1
STOCKHOLDERS' EQUITY (Tables)
3 Months Ended
Mar. 31, 2025
STOCKHOLDERS' EQUITY  
Schedule of common stock issued roll forward

 

Three Months Ended March 31,

2025

2024

Common stock:

Balance, beginning of period

195,028,207

183,606,708

Shares issued for stock options exercised

56,412

211,158

Agent growth incentive stock-based compensation

446,657

353,688

Agent equity stock-based compensation

2,004,995

2,189,922

Balance, end of period

197,536,271

186,361,476

Changes in the Company's stock compensation liability

Amount

Balance, December 31, 2023

$ 5,000

Stock grant liability increase year to date

2,251

Stock grants reclassified from liability to equity year to date

(2,206)

Balance, December 31, 2024

$ 5,045

Stock grant liability increase year to date

622

Stock grants reclassified from liability to equity year to date

-

Balance, March 31, 2025

$ 5,667

Schedule of shares repurchased

Three Months Ended March 31,

2025

2024

Treasury stock:

Balance, beginning of period

40,894,822

28,937,671

Repurchases of common stock

472,319

2,577,242

Balance, end of period

41,367,141

31,514,913